Status:
COMPLETED
Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control
Lead Sponsor:
American Heart Association
Conditions:
Glycemic Control
Eligibility:
All Genders
18-90 years
Phase:
PHASE1
Brief Summary
This study seeks to determine whether varying the dose of insulin and glucose in diabetic patients during coronary bypass surgery will improve outcomes in these patients.
Detailed Description
Our previous study has shown that maintaining serum glucose between 120-180mg/dl in the perioperative period during CABG surgery in diabetic patients improves outcomes. The purpose of this trial is: (...
Eligibility Criteria
Inclusion
- Diabetic CABG patients
Exclusion
- Renal and hepatic failure
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00460499
Start Date
July 1 2004
End Date
March 1 2015
Last Update
June 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118